CYP2A6 and lung cancer: In an earlier report, using a genome-wide association study approach in two independent studies, we showed that the top six CYP2A6 variants associated with lung cancer risk (n = 13,479 cases and 43,218 controls) were also associated with CYP2A6 activity [19].